Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Why Did Immunotherapy Pioneer NewLink Genetics Reach A 52-Week High?
Why Did Immunotherapy Pioneer NewLink Genetics Reach A 52-Week High?
Why Did Immunotherapy Pioneer NewLink Genetics Reach A 52-Week High?
Submitted by
admin
on June 10, 2013 - 12:23pm
Source:
Seeking Alpha
News Tags:
immunotherapy
NewLink Genetics
Roche
Genentech
Bristol-Myers Squibb
Merck
HyperAcute Lung
HyperAcute Pancreas
Headline:
Why Did Immunotherapy Pioneer NewLink Genetics Reach A 52-Week High?
Do Not Allow Advertisers to Use My Personal information
